Advertisement

Topics

Third Time Lucky? Sun’s Ampyra Generic Appears On Course To Indian Debut

03:14 EDT 10 Aug 2017 | SCRIP

Amid all the heat around the patents for Acorda Therapeutics’ multiple sclerosis therapy Ampyra (dalfampridine) in the US, Sun Pharma...

      

Related Stories

 

Original Article: Third Time Lucky? Sun’s Ampyra Generic Appears On Course To Indian Debut

NEXT ARTICLE

More From BioPortfolio on "Third Time Lucky? Sun’s Ampyra Generic Appears On Course To Indian Debut"

Quick Search
Advertisement
 

Relevant Topic

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...